Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal Carcinoma	Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease	Active, not recruiting	Phase 3	2026-05-29		NCT05211232

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Affiliated Hospital of Guangdong Medical University	27
Cancer Hospital of Guizhou Province	8
Hunan Cancer Hospital	66
Sun Yat-sen University	606
Wuzhou Red Cross Hospital	20

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Guizhou Cancer Hospital	Guiyang	China	2
Hunan Cancer Hospital	Changsha	China	87
The Affiliated Hospital of Guangdong Medical College	Zhanjiang	China	1
Wuzhou Red Cross Hospital	Wuzhou	China	5